RecallRadar

FDA Drug recall D-0938-2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured b…

On 2023-07-19 the FDA classified a Class I recall of Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured b… by Cipla Usa, citing defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0938-2023
ClassificationClass I
Statusterminated
Initiated2023-06-27
Published2023-07-19
Last updated2026-09-13 11:52 UTC
CompanyCipla Usa
DistributionUS

Product

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60

Reason

Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

Identifiers

ndc69097-142-60
code_infoLot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0938-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.